Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical immunologic studies in systemic lupus erythematosus.

R C Williams, A D Bankhurst

    Arthritis and Rheumatism
    |June 1, 1978
    PubMed
    Summary

    This review explores key areas in systemic lupus erythematosus (SLE) immunology, including lymphocyte markers, antigen binding, immune complexes, and hyporesponsiveness. Further research is needed to clarify T-cell reduction and T-lymphocyte hypofunction mechanisms in SLE patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?

    Scandinavian journal of rheumatology·2011
    Same author

    Pressure generated by syringes: implications for hydrodissection and injection of dense connective tissue lesions.

    Scandinavian journal of rheumatology·2011
    Same author

    The incidence of serologic evidence of antecedent autoimmune thyroiditis in asymptomatic patients referred to an outpatient rheumatology consultation clinic for a positive antinuclear antibody test.

    Clinical and experimental rheumatology·2007
    Same author

    A randomised controlled trial of the reciprocating syringe in arthrocentesis.

    Annals of the rheumatic diseases·2005
    Same author

    Lysophosphatidylcholine and arachidonic acid are required in the cytotoxic response of human natural killer cells to tumor target cells.

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2000
    Same author

    Etanercept and methotrexate combination therapy.

    Clinical and experimental rheumatology·1999

    Area of Science:

    • Clinical immunology
    • Systemic Lupus Erythematosus (SLE) research
    • Immunopathology

    Background:

    • Systemic Lupus Erythematosus (SLE) involves complex immune dysregulation.
    • Key areas of investigation include lymphocyte surface markers, antigen binding, immune complexes, and lymphocyte hyporesponsiveness.
    • Understanding these immunological aspects is crucial for SLE pathogenesis and treatment.

    Purpose of the Study:

    • To review recent advancements and new directions in the clinical immunologic study of SLE.
    • To focus on specific immunological components: lymphocyte surface markers, antigen binding lymphocytes, immune complexes, and lymphocyte hyporesponsiveness.
    • To highlight areas requiring further investigation in SLE immunology.

    Main Methods:

    • Literature review of recent and emerging clinical immunologic studies in SLE.

    Related Experiment Videos

  • Analysis of findings related to T-lymphopenia, DNA-binding B lymphocytes, immune complexes, and T-lymphocyte hypofunction.
  • Discussion of potential mechanisms and future research directions.

    • Main Results:

    • The etiology of T-lymphopenia in SLE remains unclear, with possibilities including viral destruction, anti-lymphocyte antibodies, or tissue sequestration.
    • Increased DNA-binding B lymphocytes in active SLE may stem from altered immunoregulatory T cells or bypassed DNA-specific helper T cells.
    • The role of immune complexes in lupus glomerulitis suggests potential therapeutic strategies involving extracorporeal immune absorbents.
    • Mechanisms underlying T-lymphocyte hypofunction are unexplained, possibly involving suppressive humoral agents or prostaglandin secretion from leukocyte subpopulations.
    • Investigating lymphocyte subpopulations reactive with virus-infected fibroblasts may elucidate immunoregulatory roles in SLE pathogenesis.

    Conclusions:

    • Further research is essential to elucidate the causes of T-lymphopenia and T-lymphocyte hypofunction in SLE.
    • Exploring the therapeutic potential of immune complex removal warrants consideration for SLE treatment.
    • Identifying specific lymphocyte subpopulations and their interactions is key to understanding SLE immunopathogenesis.